Alterola Biotech, Inc.
ABTI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$291.9K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $291,900.00 |
|---|---|
| Enterprise Value | $2.56 Million |
| Earnings per Share | $0 |
| Beta | 1.52 |
| Outstanding Shares | 800,109,341 |
Return
| Return on Equity | 59.18% |
|---|---|
| Return on Assets | -240.65% |
| Return on Invested Capital | 65.15% |
Valuation & Multiples
| P/E Ratio | -0.11 |
|---|---|
| PEG | 0.16 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.94 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -1.12 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Alterola Biotech, Inc.
1 employees
CEO: David John Hitchcock
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal h...